Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade

Immune checkpoint inhibitors are a powerful new tool in the treatment of cancer, with prolonged responses in multiple diseases, including hematologic malignancies, such as Hodgkin lymphoma. However, in a recent report, we demonstrated that the PD-1 inhibitor nivolumab led to rapid progression in pat...

詳細記述

保存先:
書誌詳細
出版年:Blood
主要な著者: Rauch, Daniel A., Conlon, Kevin C., Janakiram, Murali, Brammer, Jonathan E., Harding, John C., Ye, B. Hilda, Zang, Xingxing, Ren, Xiaoxin, Olson, Sydney, Cheng, Xiaogang, Miljkovic, Milos D., Sundaramoorthi, Hemalatha, Joseph, Ancy, Skidmore, Zachary L., Griffith, Obi, Griffith, Malachi, Waldmann, Thomas A., Ratner, Lee
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2019
主題:
Immunobiology and Immunotherapy
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839957/
https://ncbi.nlm.nih.gov/pubmed/31467059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002038
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料